&w=3840&q=100)
Oyo adds over 3,500 corporate clients in FY25, records 20% growth
In terms of top-performing markets, Mumbai led the charge, adding over 700 new corporate clients in the past year. Hyderabad followed with 400, while Pune secured the third spot with 350 new additions. Other major metropolitan hubs, including Chennai and Bangalore, also contributed to the overall growth in corporate accounts, the company said. Some top additions include brands such as SBI Life, Cult Fit, and Sun TV Direct.
In addition, the company's corporate travel business witnessed a boost following the launch of Oravel Travel Solutions in October 2024. 'This dedicated business vertical caters exclusively to the travel and accommodation needs of corporate clients such as smooth check-ins at more than 1,100 conveniently located company-serviced hotels in over 300 cities, tailored meal options, conference facilities, and event management support as well as tailor-made holiday packages,' the company said, adding that it has recorded a surge in long stays and event-based stays with corporate clients.
Commenting on the growth, Manish Kashyap, head of Oyo Business Accelerator, said, 'The growth has been driven not just by large corporations but also by a diverse mix of small and medium enterprises, traditional business houses, start-ups, travel management companies, and even film production houses. These clients are increasingly leveraging Oyo's expansive network of properties, flexible booking solutions, and technology-enabled travel tools to meet their evolving business needs.'
With a pipeline of potential partnerships and continued focus on innovation in corporate travel, Oyo aims to accelerate its expansion with a focus on premium brands such as SUNDAY, Palette, Clubhouse Townhouse, Townhouse O, and Collection O.
In a recent townhall, Ritesh Agarwal, founder and CEO of the company, said that the firm posted a profit of ₹623 crore for FY25. The firm has also seen an increase of 54 per cent in gross booking value to ₹16,436 crore.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
an hour ago
- Economic Times
Breakout Stocks: How to trade Torrent Pharma, SBI Life and eClexr that hit fresh 52-week high?
Indian markets closed negatively for the second straight day, with the BSE Sensex dropping over 700 points and the Nifty50 falling below 24900. Healthcare saw buying interest, while oil & gas, power, utilities, and capital goods experienced selling pressure. Analysts suggest holding Torrent Pharma, considering buying SBI Life on dips, and avoiding eClerx due to potential reversal signals. Tired of too many ads? Remove Ads We spoke to an analyst on how one should look at these stocks the next trading day entirely from an educational point of view: Analyst: Kunal Kamble, Sr. Technical Research Analyst at Bonanza Torrent Pharma: HOLD Tired of too many ads? Remove Ads SBI Life Insurance: Buy On Dip Tired of too many ads? Remove Ads eClerx: Avoid The Indian market closed in the red for the second consecutive day in a row on Friday. The BSE Sensex fell more than 700 points while the Nifty50 closed below buying was seen in healthcare while selling was seen in oil & gas, power, utilities and capital that hit 52-week high include names like Torrent Pharma which rose more than 2%, SBI Life gained nearly 2% and eClerx pared gains and closed 0.3% lower on Pharma has given a breakout above the falling trendline (initiated on 23rd June 2025) and has now also surpassed its previous swing high, confirming a bullish rise in volume during the breakout session reflects strong buying interest at current levels. The price is trading above all key EMAs, which suggests the broader trend remains RSI has broken above its resistance zone, pointing toward rising momentum. On the directional front, DI+ is above DI-, and the ADX is trending higher, indicating growing strength in the ongoing up stock has opened the path for a potential upside towards 3800–4200. Hold long positions with a trailing stop-loss at Life is currently consolidating near its resistance zone, reflecting a tug-of-war between buyers and sellers. While buyers are showing interest on dips, the inability to surpass the resistance suggests hesitation at higher RSI flattening at the upper range signals a pause in momentum, and the directional indicators (DI+, DI-) are converging, which reflects a lack of clear a flat ADX confirms the absence of strength in the ongoing move. The stock is likely to remain range bound in the short term, but dips may continue to attract buying interest. Accumulation on declines could be is currently trading near its resistance zone and has formed a shooting star pattern on the weekly chart, which serves as an early indication of potential recent rise in price accompanied by declining volume reflects weakening conviction in the ongoing up move. The momentum indicator (RSI) is slipping from higher levels, suggesting a possible loss of setup indicates caution at current levels. A move above ₹3882, backed by strong volume, would be required to validate further upside. Avoid fresh entries at current levels. Wait for a breakout above ₹3882 with volume confirmation for any bullish consideration.: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)
Mint
an hour ago
- Mint
Stocks to buy under ₹100: Experts recommend four shares to buy today — 28 July 2025
Stocks to buy under ₹ 100: The Indian stock market extended its selling for the second straight session on Friday. The Nifty 50 index broke below the 50-DEMA support and finished nearly 400 points lower from the weekly high at 24,837. This marks Nifty's fourth consecutive week of losses, with a weekly decline of 0.53%. On Friday, Cipla, SBI Life, and Apollo Hospitals demonstrated strength in a broadly negative market, standing out as the Nifty's top performers. Conversely, it was a tough session for financial heavyweights, with Bajaj Finance, Shriram Finance, and IndusInd Bank ending as the major losers. Trading volumes on the NSE cash market were lower by 4% compared to yesterday. Baring, Nifty Pharma and Healthcare, and all other sectoral indices ended in red. Nifty Media, PSU Banks, Oil & Gas, and Metal fell sharply, registering the steepest declines and bearing the brunt of the selling pressure. The pain was even more acute in the broader market today, with the Nifty Midcap 100 and Smallcap 100 indices significantly underperforming the benchmark. The Nifty Midcap 100 Index plunged 1.61%, while the Nifty Smallcap 100 Index plummeted 2.10%. Market breadth remained weak for the seventh day, where declining shares surpassed advancers. The advance-decline ratio on the BSE stood at 0.40, the lowest since 19 June. On the outlook of the Indian stock market today, Siddhartha Khemka, Head of Research — Wealth Management, Motilal Oswal, said, "We expect the market to remain in consolidation mode amid continued uncertainty around the India-US trade deal, a mixed Q1FY26 earnings season so far, and intensifying FII outflows. Key results over the weekend include Kotak Mahindra Bank, Macrotech Developers, and CDSL, amongst others." Speaking on the outlook of the Nifty 50 today, Rajesh Bhosale, Equity Technical Analyst, Angel One, said, "The chart structure has deteriorated for the bulls. On the daily chart, the Nifty 50 had been trading within a "Rising Channel" pattern since May. However, this week's breakdown below the channel's lower boundary confirms a bearish reversal. Importantly, this breakdown is accompanied by a bearish gap, which qualifies as a "Breakaway Gap", adding further conviction to the bearish setup. Additionally, the index has broken below the 50-DEMA, a level that had previously provided strong support. This shift marks a significant change in short-term momentum for the bears. On the indicator front, the RSI Smoothened has slipped below 39, a level not seen since the April swing lows, reinforcing the weakening trend. These signals suggest the potential for deeper downside, possibly towards the 200-day SMA, which lies in the 24,200–24,000 zone. For the coming week, immediate support is placed near the 89-day EMA at 24,650, followed by the 24,500 level, which has acted as a strong base during the May–June consolidation phase. On the upside, the bearish gap and the 50-DEMA zone around 24,950–25,000 now act as immediate resistance, while the 25,250 level, the high of the last two weeks, remains a stiff barrier." Asked about the outlook of the Bank Nifty today, Shiju Kuthupalakkal, Senior Manager of Technical Research at Prabhudas Lilladher, said, "The Bank Nifty index continued with the slide with a weak candle indication on the daily chart, and once again is on the way to retest the important 50-DEMA zone near the 56,000 level, which is the crucial support. The index needs to sustain the 50-DEMA zone to keep the bias intact; otherwise, it can trigger a fresh downward slide in the coming sessions. At the same time, on the upside, Parekh added that the tough resistance barrier near the 57,300 zone needs to be breached decisively to expect fresh upward movement and strengthen the trend." Regarding stocks to buy today, market experts — Vaishali Parekh, Vice President — Technical Research at Prabhudas Lilladher; Mehul Kothari, Deputy Vice President — Technical Research at Anand Rathi; Sugandha Sachdeva, Founder of SS WealthStreet; and Anshul Jain, Head of Research at Lakshmishree Investment, recommended these four intraday stocks for today — Bodal Chemicals, IOB, Hazoor Multi Projects, and DCW. 1] Bodal Chemicals: Buy at ₹ 74.40, Target ₹ 78, Stop Loss ₹ 72. 2] IOB: Buy at ₹ 37 to ₹ 38, Target ₹ 42, Stop Loss ₹ 36. 3] Hazoor Multi Projects: Buy at ₹ 39.50, Targets ₹ 41.70, ₹ 42.50, Stop Loss ₹ 38.50. 4] DCW: Buy at ₹ 79, Target ₹ 85, Stop Loss ₹ 75. Disclaimer: The views and recommendations above are those of individual analysts or brokerage companies, not Mint. We advise investors to check with certified experts before making any investment decisions.
Mint
2 days ago
- Mint
OYO's Ritesh Agarwal says India-UK FTA deal game-changer for startups, jobs, AI growth
OYO Rooms founder and CEO Ritesh Agarwal hailed the India-UK FTA deal, stating that the agreement is likely to be a game-changer for startups, jobs, AI growth. 'The India- UK FTA is a major step forward— other industries travel, services and startups are going to see a major uplift. As one of the fastest growing investors in the UK with 220+ hotels in 65+ UK cities and £50m investment in premium expansion, it means more jobs (1,000+ planned), smarter AI innovation, and a stronger role in local communities,' the OYO founder said in a clip posted on Instagram. The OYO rooms founder was among the eight other business tycoons, including Bharti Enterprises chairman Sunil Mittal, Vedanta Resources Chairman Anil Agarwal, others who attended the signing of the historic deal between India and the UK. India and the UK, on Thursday, July 25, signed a landmark free trade agreement, aimed at boosting goods and services trade between the two countries. It was signed by Piyush Goyal and his British counterpart Jonathan Reynolds in the presence of Prime Minister Narendra Modi and UK prime minister Keir Starmer. The FTA will cut tariffs on most products traded between India and the United Kingdom. According to an official release, the deal also specified that the average tariff on UK products will fall from the current 15% to just 3%. The Free Trade deal will exempt at least 75,000 Indians working in the UK from social security payments for three years. Youth in IT, services, and education will gain from easier access to the UK's high-value markets. Union Minister Piyush Goyal said the FTA would allow duty-free access for 99 per cent of Indian exports, unlocking $23 billion in opportunities for labour-intensive sectors. India's seafood shrimp, tuna, fishmeal gets zero-duty entry to the UK's $5.4 billion marine market after the Free Trade deal comes into effect. The FTA will also make it easier for British firms to export whisky, gin, cosmetics, medical devices, cars and other products to India The Free Trade deal will also offer simplified customs, equal treatment and procurement access. MSMEs can now bid for the UK government contracts.
